RecruitingPHASE1, PHASE2NCT06630234
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
Studying Gastrointestinal stromal tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Principal Investigator
- Clinical TeamDeciphera Pharmaceuticals, LLC
- Intervention
- DCC-3009(drug)
- Enrollment
- 120 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2028
Study locations (10)
- HonorHealth, Scottsdate, Arizona, United States
- UC San Diego Moores Cancer Center, La Jolla, California, United States
- University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- START Midwest, Grand Rapids, Michigan, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Vanderbilt University-Ingram Cancer Center, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06630234 on ClinicalTrials.govOther trials for Gastrointestinal stromal tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07171203Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal TumorUniversity of California, San Diego
- RECRUITINGNANCT07405125Safety of Robotic Surgery for GISTs at Special Anatomic SitesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE3NCT07218926A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyGlaxoSmithKline
- RECRUITINGPHASE1NCT06655246A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Kura Oncology, Inc.
- RECRUITINGNANCT06926374Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic SurgeryChinese University of Hong Kong
- RECRUITINGNANCT07411118RCT of EFTR Versus STER for GIST TreatmentChinese University of Hong Kong
- RECRUITINGPHASE3NCT06640361A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT06208748SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GISTSarcoma Alliance for Research through Collaboration